Isolated canine islets transplanted to hyperglycemic rats fail to restore euglycemia in almost all cases, al though the grafted islet tissue appears to be morphologically intact for up to 48 h following transplantation. Cytokines typically produced in the xenograft environment (e.g., IL-1 and TNF) inhibit insulin biosynthesis and secretion from isolated pancreatic islets, and are associated with the production of nitric oxide (NO). To further define the relationship between NO production and islet xenotransplantation, the inhibition of NO in a splenocyte/islet coculture system, and the in vivo effect of this inhibition on canine islet xenotransplanta tion, was investigated. Splenocytes (SPLC) from Lewis rats were cocultured with canine islets (freshly isolated or cultured 7 days), supernatant removed, and NO concentration (N0 2 ) determined by optical density (Griess reaction, 550 nm, expressed as nmol nitrite/10 6 cells/18 h). Lipopolysaccharide (LPS) was used as a positive control of SPLC production of NO. Stimulation by LPS resulted in maximal NO production (2.20 + 0.16 nmol/10 6 cells/18 h, p < 0.001 compared to baseline values of 0.73 + 0.04 nmol/10 6 cells/18 h). In the presence of NO inhibitors (NMA, polymyxin B, hydrocortisone, aminoguanidine, DMSO), nitrite levels did not significantly rise above unstimulated values. Freshly isolated canine islets did stimulate NO production (1.26 ± 0.12 nmol/10 6 cells/18 h,p<0.001). In contrast, cultured canine islets did not stimulate NO produc tion (0.84 + 0.09 nmol/10 6 cells/18 h). Transplantation of freshly isolated canine islets to STZ-diabetic recipi ent Lewis rats resulted in amelioration of hyperglycemia in only 50% (n = 6) of recipients 12 h posttrans plant, with a return to hyperglycemia at all subsequent time points. Transplantation of 7-day cultured canine islets resulted in amelioration of hyperglycemia in 88% of recipients 12 h posttransplant and 63% of recipi ents 24 h posttransplant [p = 0.028, mean survival time (MST) = 1.0 days, n = 8]. Transplantation of canine islet xenografts with aminoguanidine therapy (BID, n= 11) resulted in amelioration of hyperglycemia in 100% of recipients at 12 h posttransplant, decreasing to 82% by 24 h following transplantation (p = 0.002, MST = 0.9 days). These results demonstrate that freshly isolated canine islets are potent stimulators of NO production by rat SPLC in vitro, and that culture of canine islets, or addition of NO inhibitors, abrogates stimulated NO production. These results also demonstrate a statistically significant improvement (p < 0.001) in early function of canine islet xenografts following 7 days of islet culture prior to transplant, and following recipient treatment with aminoguanidine. These studies suggest that the production of NO in the microenvironment of the graft site may adversely affect engraftment and function of canine islets, and suggest that the abrogation of islet-stimulated NO production may improve engraftment following islet xenotransplantation.
INTRODUCTION
Successful xenotransplantation of isolated islets re quires that inflammatory reactions be avoided, and that the transplanted tissue successfully engraft and function.
Xenotransplantation of canine (5) or human (36) islets to nonimmunosuppressed, streptozotocin (STZ)-diabetic mice restores host normoglycemia during the period prior to islet graft destruction via immune rejection. In contrast, canine or human islet xenotransplantation in immunocompetent, STZ-diabetic rats rarely results in the reversal of recipient hyperglycemia despite evidence that normal insulin biosynthesis and secretion occurs in transplanted islets prior to neovascularization and en graftment, as demonstrated by the rapid return to eugly cemia following allogeneic islet transplantation in rats.
Islet xenograft primary nonfunction (variably described as the persistence of hyperglycemia following islet trans-plantation) occurs too rapidly to be accounted for by classical immunological pathways.
Free radicals, including nitric oxide (NO), are hy pothesized to be mediators of islet damage and destruc tion in an in vitro rodent model (10) , and rat pancreatic islet cells have been shown to be especially susceptible to NO-mediated damage when exposed to chemically generated NO from ex vivo sources (22) . The synthesis and production of an inducible isoform of nitric oxide synthase (iNOS), resulting in subsequent NO produc tion, has been linked to the toxicity and tissue destruc tion following exposure of islets to specific cytokines (including IL-1, TNF, and IFN-y) (7, 22) . Further, NO produced by hematogenous cells (lymphocytes, macro phages, or other APCs) resident within islets may play a role in the insulitis and islet cell destruction that results in autoimmune diabetes mellitus (9) . It has been theorized that damage resulting from the rapid production of NO and other free radicals at the transplant site may nega tively affect xenogeneic islet function by affecting insulin biosynthesis and secretion. Although some reports sug gest that some cytokine-induced islet toxicity is not di rectly mediated by cytokine stimulation of iNOS and NO production (41) , evidence supports a role for NO and other free radicals in cytokine-induced islet dysfunction and/or destruction. It is, therefore, logical to consider that a similar process may be involved in the early loss of islet function observed in xenografted islet tissue.
In previous studies investigating the production of NO by mouse and rat spleen cells it was found that, in coculture with rat splenocytes (SPLC), human pancre atic tissue was a potent stimulator of NO production (20) . Fresh pancreatic fragments and collagenasedigested human pancreatic tissue (prior to islet purifica tion) were shown to be strongly stimulatory of NO pro duction by rat SPLCs. Interestingly, however, human is lets, purified by discontinuous gradient centrifugation, were found to stimulate NO production by rat spleno cytes to an even greater degree than crude pancreatic digest or fresh pancreatic fragments. These results were correlated with the failure of human pancreatic islet xe nografts to restore normoglycemia in diabetic rat recipi ents. In contrast, mouse splenocytes, in an islet/mouse SPLC coculture system, did not respond to stimulation by human islets with increased NO production. This out come also correlated with the observed function of hu man islet xenografts in mouse recipients.
The present study was undertaken to investigate the hypothesis that nitric oxide, as a potential mediator of islet cell dysfunction, could be involved in the primary nonfunction, or early islet graft failure, previously ob served in xenografts of human or canine pancreatic is lets. To investigate this issue, an SPLC/islet coculture system was used to assess NO production by rat SPLC in response to stimulation by lipopolysaccharide (LPS), by canine pancreatic islets, freshly isolated or cultured for a period of 7 days. The effect of NO inhibitors upon LPS and islet-stimulated NO production was also exam ined. Further, the effect of a 7-day period of culture, or of recipient therapy with the NO inhibitor aminoguanidine, on early canine islet xenograft function was exam ined in an in vivo canine-to-rat islet xenotransplant model.
METHODS

Animals
Canine islets were isolated from pancreata obtained from purpose-bred beagle dogs (aged = 15 months, Mar shall Farms, North Rose, NY). Splenocytes were ob tained from freshly processed spleens, aseptically re moved from 8-12-week-old male Lewis rats (Harlan Sprague-Dawley, Indianapolis, IN). Transplant recipi ents were adult male nude mice (aged 8-10 weeks), adult male nude rats (aged 8-12 weeks), and adult male Lewis rats (aged 8-12 weeks) (Harlan Sprague-Dawley).
Islet Isolation and Purification
Canine islets were isolated from freshly procured ca nine pancreata using a modification (1, 33) of the semiautomated method originally described for human islet isolation (44) . In brief, the canine pancreas was surgi cally removed, right and left pancreatic ducts cannulated, and the pancreas distended by intraductal injection of a warmed collagenase solution [37°C, collagenase type P (Boehringer-Mannheim) in M-199 supplemented with antibiotic/antimycotic (Gibco, Grand Island, NY)]. The distended pancreas was enzymatically digested in a chamber by continuous recirculation of collagenase so lution and gentle shaking. Digestion temperature was maintained at 37°C, and sampling aliquots of the recir culating pancreatic digest continuously monitored diges tion. Enzymatic digestion was quenched by addition of cold medium (4°C) when liberated islets, free of exo crine tissue, were observed in the chamber effluent, as assessed by diphenyl-thiocarbazone staining (26, 51) . The effluent from the digestion chamber was collected and the tissue was washed. Islets were purified by dis continuous density gradient centrifugation using Ficoll/ Euro-Collins solution (38) . Purified islets were used fresh (within 6 h of isolation) or following a period of culture (7 days at 37°C, in Ham's F-12 supplemented with 25% equine serum).
Spleen Cell Preparation
Spleens were aseptically removed from donor Lewis rats. Splenocytes were harvested by passage of the splenic pulp through a sterile 100-pm mesh screen, col- 
In Vitro Assay for Nitric Oxide
Following 18 h of incubation, culture supernatant (80 pi) was removed for determination of nitrite levels (final product from NO) by spectrophotometric analysis. Ni trite concentration was assayed by optical density (550 nm; Titertek plate reader), determined in quadruplicate samples (assessed against blank wells containing 80 pi M-199 with 5%FCS) by the addition of 100 pi Griess reagent (1 g AM-naphthylethylene/L H 2 0 and 10 g sul fanilamide^ 0.5 M phosphoric acid mixed in equal vol umes) (15, 40) . NO production was expressed as nmol nitrite/10 6 cells/18 h, and data were analyzed statistically by two-tailed <-test.
Islet Transplantation
Canine islets, freshly isolated or cultured for 7 days, were transplanted to the intrahepatic site via portal vein embolization. Recipient animals (adult nude mice, nude rats, and Lewis rats) were rendered diabetic by a single IV injection of streptozotocin (STZ, 300 mg/kg for mouse recipients, 65 mg/kg for rat recipients) 1 week prior to transplantation, and hyperglycemia was con firmed immediately prior to transplant. All recipient rats received approximately 5000 IEs (islet equivalents, islet mass expressed as the number of islets standardized to a size of 150 um diameter). Recipient mice received ap proximately 1000 IEs. Recipient blood glucose was monitored at 12-h intervals through 48 h, then daily. Normoglycemia was defined as a blood glucose level below 200 mg/dl. Onset of hyperglycemia was defined as the first day of 2 consecutive days with blood glucose in excess of 200 mg/dl. Recipients of freshly isolated islets were treated with aminoguanidine (AG, 50 mg/kg, BID) or were untreated (negative control).
RESULTS
Canine Islet-Stimulated NO Production
In static incubations of Lewis rat splenocytes alone nitrite levels were determined to be 0.73 ± 0.04 nmol/ 10 6 Table 1 ). These levels repre sent a percent increase to 301% compared to baseline NO (nitrite) values. LPS-stimulated NO production was significantly inhibited to near, or below, baseline values by the addition to the islet/splenocyte coculture system of all NO inhibitors examined (NMA, polymyxin B, hy drocortisone, aminoguanidine, and DMSO; p < 0.001 in all cases) ( Table 1) .
cells/18 h. Nitrite levels measured in cultures of ca nine islets alone (in the absence of SPLC), or canine islets alone with LPS, demonstrated no elevation above media alone, which was used to standardize background nitrite levels.
In vitro stimulation of Lewis rat splenocytes by LPS resulted in a significant increase in media nitrite concen trations, interpreted as an increase in NO production. Ni trite levels rose from baseline levels (spleen cells alone) to 2.20 ±0.16 nmol/10 6 cells/18 h (LPS-stimulated spleen cells) (p< 0.001) (
Freshly isolated canine islets, incubated in the islet/ SPLC coculture system in the presence of Lewis rat splenocytes, stimulated a significant increase in NO pro duction (supernatant nitrite level) compared to unstimu lated controls. Nitrite levels rose from a control value of 0.73 ±0.04 nmol/10 6 cells/18 h for SPLC alone to 1.26 ±0.12 nmol/10 6 cells/18 h for SPLC plus freshly isolated islets (p< 0.002) ( Table 1 ). This result repre sented an increase in stimulated NO production to a level 170% of that observed for unstimulated spleno cytes (experiment matched, Table 1 ). As was demon strated for LPS-stimulated NO production, incubation of freshly isolated canine islet/rat SPLC with NO inhibitors abrogated NO production to levels below controls in all cases.
To investigate the effect of in vitro culture on NO production in the islet/SPLC coculture system, isolated canine islets were cultured for a period of 7 days prior 
0.84 ± 0.09 NS+, 122% p< 0.001$, p< 0.011 *Expressed as percent of baseline control value. tCompared to baseline (control) levels of NO production. ^Compared to LPS-stimulated NO production. §Not detectable, no difference from background (media alone). fCompared to canine islet-stimulated NO production.
to incubation with Lewis rat spleen cells. Splenocyte/ cultured islet cocultures did not exhibit significant in creases in nitrite levels compared to controls (SPLC alone). Cultured canine islet-stimulated NO production (0.84 ±0.09 nmol/10 6 cells/18 h) rose insignificantly (p >0.1) above control values (SPLC alone, 0.74 ±0.06 nmol/10 6 cells/18 h) ( Table 1 ). In concurrently cultured wells, stimulation of spleen cells with LPS did result in significantly increased NO production (2.23 ± 0.24 nmol/10 6 cells/18 h, p < 0.001), indicating that the fail ure of cultured canine islet/SPLC cocultures to demon strate increased NO production was not due to an inabil ity of the spleen cell population to respond. The addition of NO inhibitors failed to produce any further decrease in NO production by rat SPLC cocultured with cultured canine islets (data not shown).
Transplantation of Freshly Isolated and Cultured Canine Islets
The functional status of freshly isolated canine islets was established by transplantation to the renal subcapsu lar site in STZ-diabetic nude mouse recipients. Canine islets engrafted and survived under the renal capsule, and functioned to reverse hyperglycemia in all cases. Duration of graft function was greater than 30 days for all recipients (n = 4). In contrast, transplantation of freshly isolated canine islets to the intrahepatic site in recipient nude rats (rendered hyperglycemic by a single injection of STZ) resulted in no observed change in gly cemic state of recipients as little as 12 h following trans plantation ( Table 2) 
DISCUSSION
Primary nonfunction, also referred to as early graft failure, is a functional assessment based solely on the failure of a graft to function immediately following transplantation, and may or may not include the rapid, immune-mediated destruction of the grafted cells/tissues observed in hyperacute rejection. Transplantation of is lets isolated from phylogenetically advanced animals (including humans and canines) into rats is characterized by a failure of the grafted tissue to function and reverse recipient hyperglycemia, even for a brief period (17) . In spite of this failure of xenotransplanted islets to demon strate posttransplant function, morphologically intact is lets may be observed in rat recipients following trans plantation (48) .
The specific dynamics of primary nonfunction in iso lated islet xenografts have not been clearly defined, al though some pertinent elements have been identified.
Immune cells present during general inflammatory re sponses, including macrophages and dendritic cells, have been shown to negatively affect islet cell viability, and to inhibit insulin biosynthesis and secretion in a dose-dependent and time-dependent manner (34) . Fur ther, recent studies have identified transcripts of several cytokines, including interleukin-1 a (IL-1 a), IL-6, IL-10, and interferon-y (IFN-y), within cells' freshly isolated islets (collagenase digestion), demonstrating the pres ence of intraislet cytokines produced by islet endocrine cells (39) . Cytokines produced by these cells, including IL-1, IFN, and tumor necrosis factor (TNF), have been definitively linked to islet P-cell dysfunction and de struction (11, 21, 31, 32, 45) . Other cytokines, such as TNF, have no apparent direct effect alone, but act synergistically to augment the effect of other cytokines (12) .
An early event in the development of insulitis, lead ing to islet cell destruction and manifest diabetes, is the migration of macrophages around and into native islets (8, 50) . Cytokine production and secretion by these cells results in the generation of free radicals (including NO and super oxide), which are hypothesized to be the pri mary mediators of cytokine-induced islet damage and dysfunction (13, 22, 25, 35) . These toxic effects have been linked to increased expression of iNOS, which catalyzes the oxidation of L-arginine to L-citrulline and produces NO as a by-product (18, 30) . Investigation has demon strated that inhibition of iNOS prevents in vitro cyto kine-induced NO production, though reduction of iNOS activity does not universally ameliorate islet dysfunction nor completely prevent reductions in DNA and insulin content observed in islet cells cocultured with cytokines (41) . Thus, free radicals, and especially NO, generated in response to cytokine production by cells within the islet, have become suspect as the primary mediators of P-cell toxicity and responsible for diabetes mellitus (42) . This hypothesis is supported by evidence that scav engers of free radicals have been shown to block cyto kine-induced islet toxicity and inhibition of glucosestimulated insulin release in vitro, and to prevent both spontaneous onset and recurrence of diabetes following therapeutic islet transplantation, in nonobese diabetic (NOD) mice (6, 37, 47, 52) .
Just as cytokine secretion and free radical production within native islets have been associated with islet de struction leading to frank diabetes, it has been hypothe sized that the production of free radicals within trans planted islets may negatively affect islet cell viability and function, and may play a significant role in islet graft primary nonfunction, which occurs too rapidly to be accounted for by classical immunological pathways.
The aim of this study was to identify a relationship between NO production and islet graft primary nonfunc tion by investigating NO production in an islet/splenocyte coculture system. A further aim of these investiga tions was to correlate in vitro islet-stimulated NO production to early islet xenograft failure (primary nonfunction) in STZ-diabetic Lewis rat recipients. The ability of freshly isolated canine islets to stimulate rat splenocytes, including splenic dendritic cells and macro phages, to stimulate NO production strongly suggests that such stimulation could also occur in vivo following islet xenotransplantation.
The results reported here demonstrate a correlation between the in vitro production of NO by rat spleen cell populations and canine islet xenograft primary nonfunc tion. Stimulation of rat SPLC by freshly isolated canine pancreatic islets resulted in significantly increased NO production, compared to baseline control values (Table   1 ). Likewise, freshly isolated canine islets failed to func tion following transplantation to STZ-diabetc Lewis rat recipients. Canine islets, cultured for 7 days prior to splenocyte/islet coculture, lost their capacity to stimulate NO production. Similarly, transplantation of 7-day-cultured canine islets resulted in a brief, but statistically significant, increase in posttransplantation islet function.
This abrogation of islet-stimulated NO production by a 7-day period of culture is striking, and may be ac counted for in two ways. First, a period of culture (in cluding washing and refeeding of the tissue) may result in a reduced capacity to stimulate NO production by promoting the loss of stimulatory elements from the islet preparation. Second, the culture of canine islets for a period of 7 days may promote the depletion of intraislet hematogenous cells, which would result in reduced in traislet cytokine and NO production.
Methods of pancreas digestion and islet isolation/ purification generally employ collagenase to digest the pancreas, and discontinuous gradient separation, using Ficoll or dextran, to obtain a purified islet preparation.
A recent report, suggesting that the collagenase used to liberate islets from pancreatic parenchyma may be re sponsible for early graft failure in clinical islet trans plantation, hypothesizes that contaminating endotoxin, derived from collagenase, may stimulate nonimmune processes leading to islet dysfunction and toxicity (49) .
Collagenase and Ficoll have both been shown to be ca pable of stimulating NO production in the in vitro NO assay system used in this study (20) . This suggests the possibility that an element (or elements) of the collagen ase or gradient solutions may be retained by islets during the isolation and purification process, resulting in in creased NO production in response to stimulation by these acquired factors. A period of culture (including washing and refeeding of the tissue) may promote the loss of these stimulatory elements from the islet prepara tion, resulting in a reduced capacity to stimulate NO production.
Studies employing nonimmunogenic perinatal rat is lets, isolated by an in vitro culture technique and never exposed to collagenase (16) , in the islet/splenocyte coculture system support the hypothesis that elements stimulatory of NO production may be acquired in vitro.
Perinatal rat islets, incubated with rat splenocytes in the islet/SPLC coculture system, failed to stimulate NO pro If antigen-presenting cells or other cells (i.e., vascular endothelium) resident within the islet play a role in the stimulation of NO production, the loss of such stimula tory cells from isolated canine islets during the culture period may reduce the capacity of cultured canine islet cells to produce the cytokine milieu necessary to stimu late rat splenocytes to NO production. It has been pre viously demonstrated that the immunogenic nature of isolated, allogeneic rodent islets is significantly reduced by a period of culture (43) , a result that has been repli cated using a variety of in vitro manipulations (14, 24, (27) (28) (29) . This reduction in immunogenicity has been at tributed to the loss of cells, capable of presenting anti gen and stimulating immune reactivity, from within the islet, including resident macrophages and dendritic cells.
The APC population consists of cells capable of cyto kine production, and in fact cytokine production is be lieved to provide the second signal that stimulates im mune responsiveness. It is, therefore, highly plausible that the culture of isolated canine islets could promote the loss of stimulatory factors acquired during isolation and purification, and/or promote the depletion of intrais let hematogenous cells, which would result in reduced intraislet cytokine and NO production by reducing or eliminating the source of stimulation of NO production.
Alternately, there are techniques that reduce NO pro duction by intervening in the chemical process that yields NO. Administration of substrates such as L-Nmonomethyl-arginine (NMA) or aminoguanidine block the oxidation of arginine by NOS by competitive inhibi tion, and thereby reduce NO generation (22, 30) . In this study, the addition of known inhibitors of NO produc tion, including NMA and aminoguanidine, to the islet/ splenocyte coculture system did result in the reduction of NO production induced by freshly isolated, xenoge neic canine islets (Table 1) . NO production was signifi cantly inhibited to levels at, or below, baseline control values, and suggested the potential efficacy of in vivo therapy using an NO inhibitor.
As reported above, aminoguanidine was effective at inhibiting in vitro NO production stimulated by freshly isolated canine islets, and is known to be well tolerated in vivo. Thus, recipients of freshly isolated canine islet xenograft were treated with aminoguanidine at a dose reported to be maximally effective without deleterious effect upon islet P-cell function (19) . In these recipients mean survival time increased from 0.0 days in untreated recipients to 1.2 ±0.1 days (p< 0.001) in aminoguanidine-treated recipients, a result similar to that observed with transplantation of 7-day cultured canine islets (MST = 0.9 days, p < 0.01 compared to fresh islet xeno grafts). Similarly, other recent reports have demon strated an effect of NO inhibitors on islet transplant re sults, demonstrating improved early islet function following transplantation. In these studies, islets were treated with an NO inhibitor by IP administration of NMA to islet recipients (2, 3, 46) , or by in vitro addition of aminoguanidine to islet cultures prior to transplanta tion (4).
These results support the hypothesis that the produc tion of NO in response to cytokine release in the microenvironment of the islet graft site affects islet cell func tion in vivo, an effect that may play a role in primary nonfunction of xenogeneic islet grafts. The reduction in nitrite (NO) production, observed when rat splenocytes were stimulated by cultured canine islets, and the in creased mean survival time of xenografts of cultured ca nine islets, suggest that a period of culture prior to trans plantation modifies the microenvironment surrounding xenotransplanted canine islets by reducing NO levels present at the graft site. A similar improvement in early canine islet xenograft function in recipients treated with aminoguanidine further supports the hypothesis that early islet graft nonfunction may be mediated, at least in part, by intragraft NO.
Although the complete abrogation of canine islet pri mary nonfunction was not achieved in these studies, the observation of early function of xenogeneic canine islets in Lewis rat recipients indicates that NO production does in fact play a role in primary canine islet nonfunc tion. The failure of these canine islet xenografts, after a brief period of function, suggests that other immunologi cal mechanisms (e.g., preformed natural antibody) medi ate early graft loss. Nevertheless, these studies suggest that islet pretreatment by extended culture, coupled with islet and/or recipient treatment with an inhibitor of NO production, may reduce intraislet nitric oxide and positively influence engraftment and viability of grafted islets. Such a strategy could be applicable in allogeneic islet transplantation and result in decreased NOmediated islet dysfunction in the early posttransplant pe riod.
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